Wintrust Investments’s AdaptHealth AHCO Stock Holding History

Wintrust Investments’s Portfolio AHCO Stock Details AHCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	$23K	Sell	2,500 -2,500	-50%	-$25.3K	0.02%	364
2024 Q3	$56K	Sell	5,000 -45,000	-90%	-$478K	0.04%	299
2024 Q2	$500K	Hold	50,000	–	–	0.04%	286
2024 Q1	$576K	Hold	50,000	–	–	0.05%	263
2023 Q4	$365K	Hold	50,000	–	–	0.04%	328
2023 Q3	$455K	Hold	50,000	–	–	0.05%	272
2023 Q2	$609K	Hold	50,000	–	–	0.06%	240
2023 Q1	$622K	Hold	50,000	–	–	0.08%	181
2022 Q4	$961K	Hold	50,000	–	–	0.13%	145
2022 Q3	$939K	Hold	50,000	–	–	0.12%	149
2022 Q2	$902K	Hold	50,000	–	–	0.11%	157
2022 Q1	$802K	Hold	50,000	–	–	0.08%	194
2021 Q4	$1.22M	Hold	50,000	–	–	0.12%	147
2021 Q3	$1.17M	Hold	50,000	–	–	0.16%	106
2021 Q2	$1.37M	Hold	50,000	–	–	0.14%	129
2021 Q1	$1.84M	Buy	+50,000	New	+$1.77M	0.19%	106
2020 Q4	–	Sell	-50,000	Closed	-$1.09M	–	184
2020 Q3	$1.09M	Hold	50,000	–	–	0.15%	125
2020 Q2	$805K	Hold	50,000	–	–	0.11%	143
2020 Q1	$800K	Hold	50,000	–	–	0.13%	126
2019 Q4	$549K	Buy	+50,000	New	+$497K	0.08%	194

Other funds holding AHCO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

OCA

OEP Capital Advisors New York $170M AUM 10.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

SkyKnight Capital San Francisco, California $94.1M AUM 10.85% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Reinhart Partners Mequon, Wisconsin $4.38B AUM 55.55% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $8.43B AUM 52.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wintrust Investments's AHCO Position: Q4 2024 in Review

Wintrust Investments reduced its AdaptHealth (AHCO) stake by 50% in Q4 2024, selling an estimated $25.3K and leaving 2,500 shares worth $23K. The position accounts for 0.02% of the portfolio, ranked #364.

Wintrust Investments first reported a position in AHCO in Q4 2019 and has held it in 20 quarters since. The position peaked at $1.84M in Q1 2021. 200 funds tracked by Wall St. Rank hold AHCO as of Q4 2024.

Wintrust Investments held 2,500 shares of AdaptHealth worth $23K as of Q4 2024.
Wintrust Investments sold 2,500 AdaptHealth shares in Q4 2024, an estimated $25.3K.
AdaptHealth made up 0.02% of Wintrust Investments's portfolio in Q4 2024, its #364 holding.
Wintrust Investments first reported a position in AdaptHealth in Q4 2019 and has held it in 20 quarters since.
Wintrust Investments's AdaptHealth position peaked at $1.84M in Q1 2021.
200 funds tracked by Wall St. Rank held AdaptHealth as of Q4 2024.

Based on Wintrust Investments's 13F filing for Q4 2024, filed 10 Feb 2025.